Vedolizumab-4002

· Takeda

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vedolizumab-4002, covering 2020-10-27 to 2020-10-27. Get the full timeline:

Most recent: Clinical Trial Update: Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction Study [Phase 4]